Gottlieb A, Natsis NE, Kerdel F, Forman S, et al. A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain. J Invest Dermatol 2020;140:1538-1545.
PMID: 32004568